Episode Details

The UK's MHRA has issued Device Safety Information notice DSI/2026/007, warning of non-compliant medical devices on the UK market lacking valid UKCA or CE marking. This episode breaks down the immediate actions required for healthcare providers and suppliers, such as quarantining suspect products and reporting to the MHRA. We also explore the critical implications for manufacturers, focusing on the need for enhanced post-market surveillance and rigorous supply chain oversight to prevent patient risk and ensure compliance with UK MDR 2002. Key Questions: - What is the significance of the UK MHRA's Device Safety Information notice DSI/2026/007? - Which devices are affected by this non-compliance warning? - What immediate steps must UK healthcare providers and distributors take? - How does this notice impact a manufacturer's post-market surveillance obligations? - Why is supply chain oversight more critical than ever for devices in the UK? - What are the risks of having non-compliant devices on the market? - How can manufacturers audit their UK distribution channels effectively? - What role does UDI and proper labeling play in preventing this issue? - What are the long-term regulatory implications for market access in the UK? Sources: - https://www.gov.uk/government/publications/mhra-safety-roundup-august-2026 How Pure Global can help: Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, helping you access global markets faster. Our experts provide strategic guidance on UKCA marking, post-market surveillance, and supply chain management to ensure ongoing compliance. We act as your local representative and use advanced AI to streamline technical dossier preparation and submission. Whether you're a startup or a multinational, we can help you navigate the complexities of the UK market. Visit https://pureglobal.com, contact us at info@pureglobal.com, or explore our free AI tools and device database at https://pureglobal.ai.